Allergenic risk assessment of cowpea and its cross-reactivity with pea and peanut.

Pediatr Allergy Immunol · 2022 · PMC10108199 · PMID 36564874

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The difference was highly significant for peanut and pea in their respective groups, reflecting the initial clinical group stratification of the participants.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.